Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
40262-8 Glucose^3M pre XXX challenge MCnc Ser/Plas Pt Qn     ACTIVE Glucose [Mass/volume] in Serum or Plasma --3 minutes pre XXX challenge   MIN DefinitionDescription     mg/dL             CHAL   40262-8         Observation       0 Glucose 3M pre chal SerPl-mCnc       N   3M pre chal; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; pre chal; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.7 2.15               mg/dL       0
40263-6 Glucose^30M post XXX challenge MCnc Ser/Plas Pt Qn     ACTIVE Glucose [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge   MIN DefinitionDescription     mg/dL             CHAL   40263-6         Observation       0 Glucose 30M p chal SerPl-mCnc       N   30M p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 2.15               mg/dL       0
40264-4 Creatinine^baseline SCnc Ser/Plas Pt Qn     ACTIVE Creatinine [Moles/volume] in Serum or Plasma --baseline   MIN DefinitionDescription     umol/L             CHAL   40264-4         Observation       0 Creat BS SerPl-sCnc       N   BS; CHEMISTRY.CHALLENGE TESTING; CR; Crea; Creat; Kidney; Level; Nephrology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.15               umol/L       0
40265-1 Creatinine^30M post XXX challenge SCnc Ser/Plas Pt Qn     ACTIVE Creatinine [Moles/volume] in Serum or Plasma --30 minutes post XXX challenge   MIN DefinitionDescription     umol/L             CHAL   40265-1         Observation       0 Creat 30M p chal SerPl-sCnc       N   30M p chal; After; CHEMISTRY.CHALLENGE TESTING; CR; Crea; Creat; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.15               umol/L       0
40266-9 Creatinine^1H post XXX challenge SCnc Ser/Plas Pt Qn     ACTIVE Creatinine [Moles/volume] in Serum or Plasma --1 hour post XXX challenge   MIN DefinitionDescription     umol/L             CHAL   40266-9         Observation       0 Creat 1h p chal SerPl-sCnc       N   1 hour; 1.0Hr; 1h p chal; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; CR; Crea; Creat; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.15               umol/L       0
40267-7 Creatinine^1.5H post XXX challenge SCnc Ser/Plas Pt Qn     ACTIVE Creatinine [Moles/volume] in Serum or Plasma --1.5 hours post XXX challenge   MIN DefinitionDescription     umol/L             CHAL   40267-7         Observation       0 Creat 1.5h p chal SerPl-sCnc       N   1 1/2 hours; 1 1/2 HR; 1.5h p chal; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; CR; Crea; Creat; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.15               umol/L       0
40268-5 Creatinine^2H post XXX challenge SCnc Ser/Plas Pt Qn     ACTIVE Creatinine [Moles/volume] in Serum or Plasma --2 hours post XXX challenge   MIN DefinitionDescription     umol/L             CHAL   40268-5         Observation       0 Creat 2h p chal SerPl-sCnc       N   120 min; 120 minutes; 120min; 2 hours; 2h p chal; After; CHEMISTRY.CHALLENGE TESTING; CR; Crea; Creat; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.15               umol/L       0
40269-3 Creatinine^2.5H post XXX challenge SCnc Ser/Plas Pt Qn     ACTIVE Creatinine [Moles/volume] in Serum or Plasma --2.5 hours post XXX challenge   MIN DefinitionDescription     umol/L             CHAL   40269-3         Observation       0 Creat 2.5h p chal SerPl-sCnc       N   2.5h p chal; After; CHEMISTRY.CHALLENGE TESTING; CR; Crea; Creat; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.15               umol/L       0
4027-9 Secobarbital PrThr Ser/Plas Pt Ord     ACTIVE Secobarbital [Presence] in Serum or Plasma   MIN DefinitionDescription                   DRUG/TOX   4027-9         Both       0 Secobarbital SerPl Ql           Addiction; Barbiturate; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Secobarb; Seconal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 1                     The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
40270-1 Creatinine^3H post XXX challenge SCnc Ser/Plas Pt Qn     ACTIVE Creatinine [Moles/volume] in Serum or Plasma --3 hours post XXX challenge   MIN DefinitionDescription     umol/L             CHAL   40270-1         Observation       0 Creat 3h p chal SerPl-sCnc       N   3h p chal; After; CHEMISTRY.CHALLENGE TESTING; CR; Crea; Creat; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.15               umol/L       0
40271-9 Creatinine^5H post XXX challenge SCnc Ser/Plas Pt Qn     ACTIVE Creatinine [Moles/volume] in Serum or Plasma --5 hours post XXX challenge   MIN DefinitionDescription     umol/L             CHAL   40271-9         Observation       0 Creat 5h p chal SerPl-sCnc       N   5h p chal; After; CHEMISTRY.CHALLENGE TESTING; CR; Crea; Creat; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.15               umol/L       0
40272-7 Creatinine^6H post XXX challenge SCnc Ser/Plas Pt Qn     ACTIVE Creatinine [Moles/volume] in Serum or Plasma --6 hours post XXX challenge   MIN DefinitionDescription     umol/L             CHAL   40272-7         Observation       0 Creat 6h p chal SerPl-sCnc       N   6h p chal; After; CHEMISTRY.CHALLENGE TESTING; CR; Crea; Creat; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.15               umol/L       0
40273-5 Creatinine^1D post XXX challenge SCnc Ser/Plas Pt Qn     ACTIVE Creatinine [Moles/volume] in Serum or Plasma --1 day post XXX challenge   MIN DefinitionDescription     umol/L             CHAL   40273-5         Observation       0 Creat 1D p chal SerPl-sCnc       N   1D p chal; After; CHEMISTRY.CHALLENGE TESTING; CR; Crea; Creat; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.15               umol/L       0
40274-3 Cortisol^15M post XXX challenge SCnc Ser/Plas Pt Qn     ACTIVE Cortisol [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge   MIN DefinitionDescription     nmol/L             CHAL   40274-3         Observation       0 Cortis 15M p chal SerPl-sCnc       N   15M p chal; 17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.15               nmol/L       0
40275-0 Cortisol^45M post XXX challenge SCnc Ser/Plas Pt Qn     ACTIVE Cortisol [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge   MIN DefinitionDescription     nmol/L             CHAL   40275-0         Observation       0 Cortis 45M p chal SerPl-sCnc       N   17-Hydroxycorticosterone; 45M p chal; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.15               nmol/L       0
40276-8 Glucose^30M post dose lactose PO SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose lactose PO   MIN DefinitionDescription     mmol/L             CHAL   40276-8         Observation       0 Glucose 30M p Lac PO SerPl-sCnc       N   30M p Lac PO; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; LTT; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.15               mmol/L       0
40277-6 Glucose^1H post dose lactose PO SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --1 hour post dose lactose PO   MIN DefinitionDescription     mmol/L             CHAL   40277-6         Observation       0 Glucose 1h p Lac PO SerPl-sCnc       N   1 hour; 1.0Hr; 1h p Lac PO; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; LTT; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.15               mmol/L       0
40278-4 Glucose^1.5H post dose lactose PO SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --1.5 hours post dose lactose PO   MIN DefinitionDescription     mmol/L             CHAL   40278-4         Observation       0 Glucose 1.5h p Lac PO SerPl-sCnc       N   1 1/2 hours; 1 1/2 HR; 1.5h p Lac PO; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; LTT; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.15               mmol/L       0
40279-2 Glucose^2H post dose lactose PO SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --2 hours post dose lactose PO   MIN DefinitionDescription     mmol/L             CHAL   40279-2         Observation       0 Glucose 2h p Lac PO SerPl-sCnc       N   120 min; 120 minutes; 120min; 2 hours; 2h p Lac PO; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; LTT; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.15               mmol/L       0
4028-7 Secobarbital MCnc Ser/Plas Pt Qn     ACTIVE Secobarbital [Mass/volume] in Serum or Plasma   MIN DefinitionDescription     ug/mL             DRUG/TOX   4028-7         Both       0 Secobarbital SerPl-mCnc       Y   Addiction; Barbiturate; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Secobarb; Seconal; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 1               ug/mL       0
40280-0 Glucose^3H post dose lactose PO SCnc Ser/Plas Pt Qn     ACTIVE Glucose [Moles/volume] in Serum or Plasma --3 hours post dose lactose PO   MIN DefinitionDescription     mmol/L             CHAL   40280-0         Observation       0 Glucose 3h p Lac PO SerPl-sCnc       N   3h p Lac PO; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; LTT; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.15               mmol/L       0
40281-8 Lactose^30M post dose lactose PO SCnc Ser/Plas Pt Qn     ACTIVE Lactose [Moles/volume] in Serum or Plasma --30 minutes post dose lactose PO   MIN DefinitionDescription     mmol/L             CHAL   40281-8         Observation       0 Lactose 30M p Lac PO SerPl-sCnc       N   30M p Lac PO; After; CHEMISTRY.CHALLENGE TESTING; Level; LTT; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.15               mmol/L       0
40282-6 Lactose^1H post dose lactose PO SCnc Ser/Plas Pt Qn     ACTIVE Lactose [Moles/volume] in Serum or Plasma --1 hour post dose lactose PO   MIN DefinitionDescription     mmol/L             CHAL   40282-6         Observation       0 Lactose 1h p Lac PO SerPl-sCnc       N   1 hour; 1.0Hr; 1h p Lac PO; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Level; LTT; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.15               mmol/L       0
40283-4 Lactose^1.5H post dose lactose PO SCnc Ser/Plas Pt Qn     ACTIVE Lactose [Moles/volume] in Serum or Plasma --1.5 hours post dose lactose PO   MIN DefinitionDescription     mmol/L             CHAL   40283-4         Observation       0 Lactose 1.5h p Lac PO SerPl-sCnc       N   1 1/2 hours; 1 1/2 HR; 1.5h p Lac PO; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Level; LTT; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.15               mmol/L       0
40284-2 Lactose^2H post dose lactose PO SCnc Ser/Plas Pt Qn     ACTIVE Lactose [Moles/volume] in Serum or Plasma --2 hours post dose lactose PO   MIN DefinitionDescription     mmol/L             CHAL   40284-2         Observation       0 Lactose 2h p Lac PO SerPl-sCnc       N   120 min; 120 minutes; 120min; 2 hours; 2h p Lac PO; After; CHEMISTRY.CHALLENGE TESTING; Level; LTT; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.7 2.15               mmol/L       0
104,672 results found